Molm13 - OmicsDI

Show results for

Genomics (163)
Unknown (42)
Transcriptomics (37)
Proteomics (22)
Other (7)

Organisms

Homo sapiens (54)
Schizosaccharomyces pombe (20)
Oryza sativa Indica Group (20)
Sinorhizobium meliloti BL225C (20)
Sus scrofa domesticus (20)
Saccharomyces cerevisiae (20)
Staphylococcus aureus (20)
Rattus norvegicus (20)
Escherichia coli (20)
Entamoeba histolytica (20)
Physcomitrium patens (20)
Methylohalobius crimeensis 10Ki (20)
Homo sapiens (20)
Shigella flexneri (20)
Danio rerio (20)
Allexis (20)
Shigella (20)
Zea mays (20)
Meleagris gallopavo (20)
Medicago truncatula (20)
Pseudomonas fluorescens WH6 (20)
Listeria monocytogenes (20)
Drosophila (20)
Callinectes sapidus (20)
Bos taurus (20)
Trypanosoma brucei (20)
Entamoeba histolytica HM-1:IMSS-A (20)
Drosophila melanogaster (20)
Mus musculus (3)
synthetic construct (1)

Organisms

Homo sapiens (121)
Mus musculus (1)

Repository

ENA (149)
geo (48)
pride (20)
biostudies-arrayexpress (8)
MassIVE (2)
NODE (2)

Tissue

Cell culture (11)
Blood cell line (2)
Leukocyte (2)
Cell suspension culture (2)
Blood cell (2)
Bone marrow (1)
Myeloid cell (1)
Permanent cell line cell (1)
Monocyte (1)
Blood (1)

Disease

Acute leukemia (7)
Acute myeloid leukemia (2)
Myeloma (1)
Lung carcinoma (1)
Lymphoma (1)
Colon cancer (1)

Technology Type

Mass Spectrometry (20)
Shotgun proteomics (13)
Affinity purification coupled with mass spectrometry proteomics (6)
Bottom-up proteomics (2)
Proteogenomics (1)
Data-independent acquisition (1)

Instrument Platform

Illumina iScan System (1)
Human-HT-12-V4 Expression BeadChip (1)
Biorad MJ Thermal Cycler (Biorad) (1)
DNBSEQ-G400 (1)
Illumina NovaSeq 6000 (1)
Orbitrap Eclipse (1)
Q Exactive HF (1)

Publication Date

2022 (18)
2021 (14)
2024 (10)
2026 (6)
2025 (6)
2023 (5)
2019 (4)
2017 (3)
2014 (3)
2020 (3)
2013 (2)
2015 (1)
2011 (1)
2010 (1)
2009 (1)

First Public Date

2025 (23)
2024 (21)
2022 (19)
2021 (19)
2023 (18)
2026 (15)
2019 (12)
2020 (10)
2017 (6)
2018 (3)
2014 (2)
2013 (1)

Modification

2x(15)N labeled L-lysine (1)

Study type

Transcription profiling by array (4)
ChIP-seq (2)
RNA-seq of coding RNA (2)

Release Date

2023 (9)
2022 (7)
2017 (5)
2024 (4)
2021 (4)
2014 (3)
2018 (3)
2013 (2)
2011 (2)
2025 (2)
2020 (2)
2019 (2)
2016 (2)
2015 (1)
2010 (1)
2026 (1)

Lab affiliation

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA (7)
Leukemia Department, MD Anderson Cancer Center, Houston, TX 77030 (2)
Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Switzerland Department for BioMedical Research (DBMR), University of Bern, Switzerland (1)
Department of Bioinformatics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China (1)
Center for Cell Engineering, Memorial Sloan Kettering Cancer Center (1)
Department of Biomedicine, PROBE, University of Bergen, Norway (1)
Department of Proteomics and Signal Transduction. MaxPlanck Institute of Biochemistry (1)
Division of Blood Cells and Blood Cancer The Walter and Eliza Hall Institute of Medical Research 1G Royal Parade, Parkville Victoria, Australia, 3050 (1)
Center of Molecular and Cellular Oncology, Yale University (1)
State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, China (1)
German Cancer Consortium (DKTK), partner site Freiburg German Cancer Research Center (DKFZ) Foundation under Public Law c/o Department of Urology Zentrale Klinische Forschung (ZKF) Medical Center-University of Freiburg Breisacher Str. 66, 79106 Freiburg, Germany (1)
Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX (1)
Institute for Research in Immunology and Cancer, Department of Biochemistry, Department of Chemistry, Université de Montréal, Québec, Canada H3T 1J4 (1)

Previous page
1 / 28
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 28
Next page

Sort by:

Relevance

Page size

CUT&Tag of ARID1B and ARID2 in MOLM13 cells

PRJNA778205 | ENA

ZFP36L2 post-transcriptionally controls acute myeloid leukemia differentiation (MOLM13 HiC)

PRJNA610800 | ENA

Idasanutlin differential expression in MOLM13 and OCIAML3

PRJNA1005281 | ENA

Transcriptomic profiling of FDX1 knockdown in MOLM13 acute myeloid leukemia cells

PRJNA1512425 | ENA

RNA-seq in human Molm13 cells with CRISPR knockout of COX4I1

PRJNA1089648 | ENA

Transcriptomic profiling of FDX1 knockdown in MOLM13 acute myeloid leukemia cells

RNA sequencing was performed to characterize transcriptomic changes associated with FDX1 depletion in acute myeloid leukemia cells. Stable FDX1-knockdown MOLM13 cells and corresponding negative-control MOLM13 cells were analyzed using three biologically independent replicates per group. The resultin...

ORGANISM(S): Homo sapiens

2026-08-18 | GSE343704 | GEO

Genome-wide maps of AF10( MLLT10) PZP binding in MOLM13 human AML cells

PRJNA685135 | ENA

miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells

We studied the following conditions: m6A RNA methylation in MOLM13 AML cells; METTL3 deficiency on gene expression and translational efficiency

ORGANISM(S): Homo sapiens

2017-09-18 | GSE98623 | GEO

Genome-wide CRISPR screen of MOLM13 cells after Idasanutlin treatment

PRJNA1005974 | ENA

RNA-seq identifies differential expressed genes upon YTHDC1 knockdown in MOLM13 human acute myeloid leukemia cells

PRJNA708303 | ENA